Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Movement Disorders : Official Journal of the Movement Disorder Society|January 5, 2008
Phenotypic spectrum and sex effects in eleven myoclonus-dystonia families with epsilon-sarcoglycan mutationsDeborah Raymond, Rachel Saunders-Pullman, Patricia de Carvalho Aguiar, et al.
Annals of Neurology|January 26, 2012
Head injury, α-synuclein Rep1, and Parkinson's diseaseSamuel M Goldman, Freya Kamel, G Webster Ross, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 28, 2019
Cervical dystonia incidence and diagnostic delay in a multiethnic populationSara C LaHue, Kathleen Albers, Samuel Goldman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 20, 2014
Peptidoglycan recognition protein genes and risk of Parkinson's diseaseSamuel M Goldman, Freya Kamel, G Webster Ross, et al.
Neuron|December 13, 2016
Functional Genomic Analyses of Mendelian and Sporadic Disease Identify Impaired eIF2α Signaling as a Generalizable Mechanism for DystoniaJoseph E Rittiner, Zachary F Caffall, Ricardo Hernández-Martinez, et al.
Neuron|March 23, 2021
Novel ultra-rare exonic variants identified in a founder population implicate cadherins in schizophreniaTodd Lencz, Jin Yu, Raiyan Rashid Khan, et al.
The Lancet. Neurology|November 4, 2019
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional studyTanya Simuni, Liz Uribe, Hyunkeun Ryan Cho, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 15, 2020
Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease PenetranceMarta San Luciano, Caroline M Tanner, Cheryl Meng, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 27, 2019
Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controlsIlir Agalliu, Roberto A Ortega, Marta San Luciano, et al.
The Lancet. Neurology|June 10, 2008
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control studyDaniel G Healy, Mario Falchi, Sean S O'Sullivan, et al.
Pageof 9